Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Calmark receives order from Vietnam

Calmark Sweden AB (publ) announces today that an order for 40 instruments and 3,000 test cassettes has been received from the Company's distributor in Vietnam, MTTS Co., Ltd, relating to the Calmark Neo-Bilirubin product. The instrument, POC- Analyzer Neo, has obtained registration in the country as disclosed on August 10. The test cassettes for bilirubin are expected to be registered shortly. Today’s order is of less economic importance, but highly significant in a launch perspective.The units with associated test cassettes will be distributed to end customers in the southern, central, and

Repurchase of NCC Series B shares in week 33, 2022

During the period August 15 – August 19, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 278,165 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

Musti Group plc – Managers' transactions – Martin-Löf

Musti Group plc – Managers' transactions – Martin-Löf Musti Group plc            Managers’ transactions                  23 August 2022, at 11.30am Musti Group Oyj - Managers’ transactions                  _________________________________________ Person subject to the notification requirement Name: Nanna Martin-Löf Position: Other senior manager Issuer: Musti Group LEI: 743700IE9NQGF9YZAI97 Notification type: INITIAL NOTIFICATION Reference number: 18696/4/4 ____________________________________________ Transaction date: 2022-08-17 Venue: NASDAQ

Freiburg, the sustainable, exciting Black Forest metropolis

Freiburg leads the way in Germany when it comes to sustainability and is a real treat not just for the greens! Climate change is already irreversible and low carbon footprint travel is the future. Holidaying on your own continent is a good start, and you can even ease your conscience by heading to one of the most sustainable cities in Germany!Pioneering in the sustainable use of resources  Freiburg is taking solar technology, transport policy, helping the environment and climate protection one step further. The development of plans to combine quality of life with sustainability,

LeDap Group appoints Eno Polo as new CEO

LeDap today announces the appointment of Eno Polo as new CEO of the LeDap Group, effective September 5. Eno Polo has a long background from consumer goods and retail businesses, having held senior executive positions with Global Brands Group, Havaianas and Nike. As a former professional tennis player, he also brings long experience from professional sports and currently serves on the Board of Directors of ATP and as a consultant to FIFA. “There is tremendous opportunity to professionalize and develop the industry, and I very much look forward to bringing my experience from the world of

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 163 - 23 AUGUST 2022  In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

Björn Larsson new CEO of RLS Global

The Board of Directors of RLS Global AB (publ) has today appointed Björn Larsson as new CEO. Björn Larsson, who joins the company from Observe Medical ASA, will assume the role of CEO on 1 October.Björn Larsson has solid experience from the global medical device and pharmaceutical industry where he has held various positions in companies such as ABIGO Medical AB and AstraZeneca.“I look forward to leading the company into the next phase and, together with the board and the team, realizing the potential of RLS' unique, patented hypochlorite platform, ChloraSolv. With my experience in the

INVITATION TO ETTEPLAN OYJ’S EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS

Etteplan Oyj, Stock Exchange Release, August 23, 2022, at 10.00 a.m. EEST INVITATION TO ETTEPLAN OYJ’S EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS The shareholders of Etteplan Oyj (“Company”) are invited to the Extraordinary General Meeting of Shareholders. The Meeting will be held on Wednesday October 19, 2022 starting at 9:00 a.m. at Leonardo auditorium, Innopoli 1 at the address Tekniikantie 12, 02150 Espoo, Finland. The reception of the shareholders who have registered for the Meeting will commence at 8:30 a.m. Shareholders can attend the meeting at the meeting venue.

Crypto service provider Coinmotion partners up with FA Solutions to accelerate institutional crypto offering

Nordic crypto asset service provider Coinmotion  has partnered with Helsinki-based cloud portfolio management platform provider FA Solutions  to expand its reporting and monitoring capabilities to better cater to institutional investors and corporations.   FA Solutions provided a solution for Coinmotion to develop and maintain its crypto asset reporting and monitoring, enabling the company to effortlessly perform the daily industry-standard actions and reporting to its institutional clients. FA Solutions’ FA Platform provided an easy-

Emissions from Viking Line’s vessels have decreased by a third in 15 years – the company’s focused environmental work began as far back as the 1980s

Over the past 15 years, Viking Line has succeeded in reducing carbon dioxide emissions from its vessels by nearly a third. Environmental investments have been made in the Baltic Sea’s most climate-smart vessels and in the technology on board every vessel. Viking Glory and Viking Grace are already equipped to start running on green fuels, which will enable truly carbon-neutral service in the future.Thursday, August 25, is Baltic Sea Day. To celebrate the occasion, Viking Line will donate 30,000 euros from the sale of plastic carrier bags in its tax-free shops to the John Nurminen Foundation.

Internet Vikings are an unstoppable force in the U.S., as they commence operations in Louisiana

Internet Vikings is pleased to announce the launch of its hosting services in Louisiana, which is yet another milestone along the road towards its nation-wide expansion across the U.S. market. Since its first bold step into the new American online gaming and sports betting market in 2021, the global iGaming hosting provider has already successfully obtained the necessary rights to legally operate and also established customer bases in multiple states, including New Jersey and Michigan.  Research reveals quite clearly that Louisiana has long held a concrete policy that

Nina Jönsson appointed as new CEO of ICA Gruppen

Per Strömberg has chosen to leave ICA Gruppen, where he has served as CEO since 2012. He will leave his CEO role on 31 December 2022. The Board of Directors has appointed Nina Jönsson as the new CEO. She is currently CEO of Plantagen, with more than 20 years of experience from various senior positions in the retail and food industries. At the beginning of 2023, Per Strömberg will be proposed as member of ICA Gruppen’s board of directors.“I am very happy that Nina Jönsson has accepted the job as CEO of ICA Gruppen,” comments Claes Göran Sylvén, Chairman of ICA Gruppen. “With the combination

Eric Lundberg new CEO of ICA Sweden, and Monika Magnusson new CEO of Apotek Hjärtat

Anders Svensson has chosen to leave ICA Sweden after 13 years in the role as CEO. Eric Lundberg, currently CEO of Apotek Hjärtat, has been named as the new CEO of ICA Sweden. In connection with this, Monika Magnusson, Director of Sales at Apotek Hjärtat, has been named to succeed Eric Lundberg as the new CEO of Apotek Hjärtat.“Today I am happy to announce the appointment of two new CEOs within ICA Gruppen, who we have recruited internally. Both are respected leaders who are passionate about developing our businesses together with all of our competent employees. At the same time, I want to

BioStock: Strong growth for Invent Medic in Q2

When Anna Lindström took over as CEO of Invent Medic just under a year ago, the focus was crystal clear – sales should be increased. After a number of new strategic initiatives, growth reached just over 60 per cent in the second quarter of 2022. At the same time, cost savings have started to show effect. The company will continue to look firmly ahead, hoping to present further growth news in the near future.Read the full article at biostock.se:https://www.biostock.se/en/2022/08/strong-growth-for-invent-medic-in-q2/This is a press release from BioStock - Connecting Innovation & Capital.

Hope for leukaemia patients through discovery at Karolinska University Hospital

In a recently published study, Nikolas Herold and Martin Jädersten from Karolinska University Hospital show how acute myeloid leukaemia can be treated more effectively. They have reused an already proven medicinal product.Acute myeloid leukaemia (AML) is an aggressive blood cancer with a high mortality that affects about 350 people annually in Sweden. Over 70 percent of patients die within five years of falling ill. One reason for the high mortality rate is that chemotherapy often has an inadequate effect, which causes the disease to reoccur after some time. The protein (SAMHD1) in the

IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study

· Dr. Christopher Kellner from Mount Sinai Health System successfully enrolled the first patients in the DIVE (Deployment of Irrigating Intraventricular Catheter System) study. · DIVE is designed to measure the effectiveness of IRRAflow to treat intraventricular hemorrhage versus standard EVD treatment. · The Neurosurgery and Neurology Departments at The Mount Sinai Hospital were recently ranked 9th in the US, according to U.S. News and World Report.Stockholm, August 23, 2022 – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products

AFRY provides basic engineering for Yash Pakka’s sustainable packaging production expansion

Yash Pakka Limited has awarded AFRY basic engineering assignment for the Ayodhya packaging material production facility expansion project in India. The expansion enables Yash Pakka to increase sustainable packaging materials production and, at the same time, continue to be low-carbon with 100% bio-based energy.Yash Pakka is a leading provider of packaging solutions in paper and compostable tableware. Company’s bagasse fiber-based products are compostable, fossil-free and low-carbon alternatives integrating bio-based solutions that provide a green alternative to single-use plastic, styrofoam

Interim report January – June 2022

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value fell to SEK 158 per share, compared with SEK 216 per share at the start of the year. This is a decrease of 25.5 per cent, adjusted for dividends. By comparison, the Stockholm Stock Exchange’s Total Return Index (SIXRX) decreased by 27.9 per cent. The net asset value was SEK 169 per share at 22 August.[1] · The total return on the Latour share was -44.3 per cent during the period measured against the SIXRX, which fell 27.9 per cent. INDUSTRIAL OPERATIONS The second quarter · The industrial operations’ order intake

Immunovia to present at Gilmartin Group’s Emerging Growth Company Showcase

LUND, SWEDEN – Immunovia today announced it will participate in Gilmartin Group's Emerging Growth Company Showcase on August 31, 2022.   Philipp Mathieu, CEO and President, and Jeff Borcherding, US CEO, are scheduled to present on Wednesday, August 31, 2022 at 9:00 am ET (15:00 pm CET).   A live and archived webcast will be available on the “Investors” section of the Immunovia website at https://investor.immunovia.com/.   For more information, please contact:Karin Almqvist LiwendahlCFOkarin.almqvist.liwendahl@immunovia.com+46 70 911 56 08  About Immunovia

Saga Pure ASA: Invitation to presentation of Q2 2022 results on 25 August 2022 at 12:00 (CEST)

In connection with the release of the results for Q2 2022, Saga Pure ASA invites to the following event: Thursday 25 May 2022 at 12.00 CET Live webcast of the company Q2 Report and Q&A. The presentation will be held at Haakon VIIs gate 2, Oslo. The Q2 Report and Presentation will be available at www.sagapure.com and by a stock exchange release from Saga Pure ASA 25 August 2022. All others are welcome follow the Q2 presentation live on webcast. Link to webcast: https://channel.royalcast.com/landingpage/hegnarmedia/20220825_9/ ENDS For additional information, please

Medivir to present at the Erik Penser Bank Company Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the Erik Penser Bank Company Day on August 24, 2022. CEO Jens Lindberg will present the company and its plan for the ongoing clinical study with fostroxacitabine bralpamide (fostrox).The presentation will be available after the meeting on Medivirs website; www.medivir.com.For additional information, please contactMagnus Christensen, CFO, Medivir ABTelephone: +46 8 5468 3100E-mail: magnus.christensen@medivir.comMedivir in briefMedivir develops innovative drugs with a focus

Etteplan is planning for a rights offering of approximately 110–125 million euros

Etteplan Oyj, Stock exchange release, Inside information, August 23, 2022 at 09:30 a.m. EEST Etteplan is planning for a rights offering of approximately 110–125 million euros NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Etteplan Oyj (the ”Company”) commences preparations for a rights offering of approximately 110–125 million euros. The subscription period for the offering is expected

The subscription period in Clinical Laserthermia Systems AB’s (publ) rights issue begins today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, OR CANADA OR ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW. Lund, Sweden – Today, 23 August 2022, is the first day of the subscription period in Clinical Laserthermia Systems AB’s (publ), (”CLS” or the “Company”) issue of units, with preferential right for existing shareholders (the “Rights Issue”). The public is also invited to subscribe

FluoGuide has submitted a Clinical Trial Application (CTA) to the Danish Medicines Agency to initiate phase II trial with FG001 in head and neck cancer

Copenhagen, Denmark 23 August2022– FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has submitted a CTA to initiate a phase II trial in head and neck cancer. The clinical trial will be conducted at Rigshospitalet in Denmark.Following approval from the Danish Medicines Agency, FluoGuide will initiate the phase II trial in collaboration with Department of Otolaryngology, Head & Neck Surgery and Audiology at the University Hospital, Rigshospitalet, in Denmark. Principal investigator is Anders Christensen, MD, Ph.D. The phase IIa trial is designed to

There are no items matching the current filter
There are no more items matching the current filter
Back to top